Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Modulation with Nivolumab in Metastatic Melanoma
NCT02626065Phase 4Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Apr 2015
- Primary completion
- Dec 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of nivolumab in melanoma, sponsored by Hospices Civils de Lyon. Started Apr 2015; status: completed.
02
Drugs
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02626065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02626065.